Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
59
BCS Quote, Financials, Valuation and Earnings
Last price:
$13.09
Seasonality move
:
2.53%
Day range:
$12.81 - $13.20
52-week range:
$7.07 - $13.83
Dividend yield:
2.76%
P/E ratio:
8.95x
P/S ratio:
1.51x
P/B ratio:
0.50x
Volume:
19.9M
Avg. volume:
11.5M
1-year change:
70.53%
Market cap:
$47.1B
Revenue:
$31.6B
EPS (TTM):
$1.46
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $27.6B | $27.7B | $30.2B | $30.6B | $31.6B | |
| Revenue Growth (YoY) | -2.07% | 0.47% | 8.87% | 1.39% | 3.15% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.6B | $2.6B | $2.7B | $2.8B | $3.2B | |
| Other Inc / (Exp) | $1.3B | -$30.8M | $400.3M | -$484.2M | $75.9M | |
| Operating Expenses | $17.1B | $17.2B | $18.7B | $18.5B | $19.1B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $5.6B | $3.9B | $11.3B | $8.7B | $8.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.3B | $775.2M | $1.6B | $1.3B | $1.5B | |
| Net Income to Company | $5.6B | $3.9B | $11.3B | $8.7B | $8.2B | |
| Minority Interest in Earnings | -$102.1M | -$100.1M | -$64.7M | -$55.7M | -$79.6M | |
| Net Income to Common Excl Extra Items | $4.2B | $3.1B | $9.6B | $7.3B | $6.5B | |
| Basic EPS (Cont. Ops) | $0.73 | $0.45 | $2.01 | $1.53 | $1.38 | |
| Diluted EPS (Cont. Ops) | $0.72 | $0.44 | $1.96 | $1.48 | $1.34 | |
| Weighted Average Basic Share | $4.3B | $4.3B | $4.2B | $4.1B | $3.9B | |
| Weighted Average Diluted Share | $4.4B | $4.4B | $4.4B | $4.2B | $4B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $13.3B | $8.8B | $15.6B | $19.2B | $36B | |
| Revenue (Reported) | $27.6B | $27.7B | $30.2B | $30.6B | $31.6B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $13.3B | $8.8B | $15.6B | $19.2B | $36B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $6.7B | $7.5B | $7B | $7.9B | $8.5B | |
| Revenue Growth (YoY) | -1.5% | 12.05% | -7.05% | 13.14% | 7.51% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $4.4B | $4.8B | $4.6B | $5B | $5.1B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $1.5B | $2.7B | $2.3B | $2.4B | $2.9B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $423.9M | $437.1M | $293.1M | $434.3M | $536.1M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$5.2M | -$1.4M | -$2.4M | -$11.4M | -$3.9M | |
| Net Income to Common Excl Extra Items | $1.1B | $2.3B | $2B | $1.9B | $2.4B | |
| Basic EPS (Cont. Ops) | $0.18 | $0.47 | $0.44 | $0.42 | $0.56 | |
| Diluted EPS (Cont. Ops) | $0.18 | $0.47 | $0.44 | $0.42 | $0.56 | |
| Weighted Average Basic Share | $4.3B | $4.3B | $4B | $3.9B | $3.7B | |
| Weighted Average Diluted Share | $4.3B | $4.3B | $4B | $3.9B | $3.7B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.5B | $2.7B | $2.3B | $2.4B | $2.9B | |
| Revenue (Reported) | $6.7B | $7.5B | $7B | $7.9B | $8.5B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $1.5B | $2.7B | $2.3B | $2.4B | $2.9B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $28.2B | $29.6B | $31.1B | $31.1B | $32.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $17B | $18.8B | $18.1B | $19.2B | $19.4B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $4.5B | $10.4B | $9.1B | $9.5B | $8.4B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $810.4M | $1.7B | $1.5B | $1.5B | $1.6B | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$105.8M | -$76.7M | -$65.2M | -$74.5M | -$67.8M | |
| Net Income to Common Excl Extra Items | $3.6B | $8.6B | $7.5B | $7.9B | $6.7B | |
| Basic EPS (Cont. Ops) | $0.59 | $1.75 | $1.57 | $1.71 | $1.47 | |
| Diluted EPS (Cont. Ops) | $0.59 | $1.75 | $1.56 | $1.70 | $1.46 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $4.5B | $10.4B | $9.1B | $9.5B | $8.4B | |
| Revenue (Reported) | $28.2B | $29.6B | $31.1B | $31.1B | $32.3B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $4.5B | $10.4B | $9.1B | $9.5B | $8.4B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $21.4B | $23.2B | $24.2B | $24.6B | $25.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $12.7B | $14.2B | $14.1B | $14.8B | $15.2B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $3.1B | $9.5B | $7.2B | $8B | $8.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $566.9M | $1.5B | $1.4B | $1.6B | $1.7B | |
| Net Income to Company | $1.6B | $6.9B | $4.7B | $5.7B | $5.3B | |
| Minority Interest in Earnings | -$51.7M | -$27.9M | -$28.8M | -$48.7M | -$36.7M | |
| Net Income to Common Excl Extra Items | $2.5B | $8B | $5.8B | $6.4B | $6.5B | |
| Basic EPS (Cont. Ops) | $0.39 | $1.69 | $1.22 | $1.40 | $1.50 | |
| Diluted EPS (Cont. Ops) | $0.39 | $1.69 | $1.22 | $1.40 | $1.50 | |
| Weighted Average Basic Share | $8.6B | $12.8B | $12.4B | $11.7B | $11.1B | |
| Weighted Average Diluted Share | $8.6B | $12.8B | $12.4B | $11.7B | $11.1B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $3.1B | $9.5B | $7.2B | $8B | $8.2B | |
| Revenue (Reported) | $21.4B | $23.2B | $24.2B | $24.6B | $25.3B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $3.1B | $9.5B | $7.2B | $8B | $8.2B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $197B | $260.5B | $322B | $310.2B | $286.2B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $629.6B | $873.2B | $876.8B | $876.9B | $806.8B | |
| Property Plant And Equipment | $5.5B | $5.5B | $4.8B | $4.4B | $4.4B | |
| Long-Term Investments | $570.6B | $724.7B | $674.7B | $658B | $710B | |
| Goodwill | $5.1B | $5.3B | $5.3B | $4.7B | $5.3B | |
| Other Intangibles | $5.5B | $5.5B | $5.6B | $5.2B | $4.6B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.5T | $1.8T | $1.9T | $1.8T | $1.9T | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $4.7B | $5.6B | $7.4B | $10.2B | $9.1B | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.4T | $1.7T | $1.8T | $1.7T | $1.8T | |
| Common Stock | $5.7B | $5.9B | $5.7B | $4.8B | $4.8B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $84.5B | $89.7B | $93.2B | $82.6B | $90.7B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $1.6B | $1.5B | $1.3B | $1.2B | $840.8M | |
| Total Equity | $86.1B | $91.1B | $94.5B | $83.8B | $91.5B | |
| Total Liabilities and Equity | $1.5T | $1.8T | $1.9T | $1.8T | $1.9T | |
| Cash and Short Terms | $197B | $260.5B | $322B | $310.2B | $286.2B | |
| Total Debt | $191B | $196.3B | $224.8B | $221.9B | $224.9B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $310B | $305.7B | $287.1B | $320.6B | $287.8B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $712.1B | $658.7B | $754.6B | $666.8B | $638.9B | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | $867.1B | $912B | $957.7B | $984B | $1.1T | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.8T | $1.9T | $1.9T | $1.9T | $2T | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $584M | $825.8M | $595.2M | $895.6M | $836.4M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.7T | $1.8T | $1.9T | $1.9T | $2T | |
| Common Stock | $6B | $6.1B | $4.9B | $5.2B | $5.6B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $1.6B | $1.4B | $1.1B | $805.3M | $883.2M | |
| Total Equity | $88.8B | $93.7B | $75.9B | $84.2B | $95.9B | |
| Total Liabilities and Equity | $1.8T | $1.9T | $1.9T | $1.9T | $2T | |
| Cash and Short Terms | $310B | $305.7B | $287.1B | $320.6B | $287.8B | |
| Total Debt | $153B | $146B | $147.5B | $139.1B | $134.8B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $5.6B | $3.9B | $11.3B | $8.7B | $8.2B | |
| Depreciation & Amoritzation | $1.9B | $2.2B | $2.3B | $2.1B | $2.2B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$641M | $73.8B | $67.3B | $37.4B | -$1.2B | |
| Capital Expenditures | $2.3B | $1.7B | $2.4B | $2.2B | $2.1B | |
| Cash Acquisitions | -- | -- | $1.5B | -- | -$3B | |
| Cash From Investing | -$30.6B | -$23.6B | $5.9B | -$26.8B | -$29.1B | |
| Dividends Paid (Ex Special Dividend) | -$2.4B | -$1.2B | -$1.9B | -$2.4B | -$2.8B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $6.8B | $9.2B | $14.2B | $15.6B | $14.1B | |
| Long-Term Debt Repaid | -$4.1B | -$4.2B | -$11.4B | -$11.2B | -$10.6B | |
| Repurchase of Common Stock | -$3.9B | -$1.8B | -$2.3B | -$5.1B | -$6.5B | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $881M | $3.5B | $147.2M | $861.9M | -$1.7B | |
| Beginning Cash (CF) | $247.4B | $213.8B | $289.1B | $321B | $346.9B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$30.4B | $53.7B | $73.3B | $11.5B | -$32B | |
| Ending Cash (CF) | $212.7B | $269.7B | $356.6B | $345.2B | $308.6B | |
| Levered Free Cash Flow | -$2.9B | $72.1B | $64.9B | $35.3B | -$3.3B | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.6B | $6.9B | $4.7B | $5.7B | $5.3B | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $68.4B | $54.4B | $78.3B | $29.9B | $47.4B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$22.1B | -$4.7B | -$18.8B | -$18.5B | -$20.6B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $3.9B | -$3.6B | -$6.9B | -$239.1M | $209.4M | |
| Beginning Cash (CF) | $206.6B | $293.7B | $325.9B | $349B | $312.9B | |
| Foreign Exchange Rate Adjustment | $9.7B | -$7.7B | $8.9B | -$7.6B | -$2B | |
| Additions / Reductions | $50.2B | $46.1B | $52.6B | $11.2B | $27B | |
| Ending Cash (CF) | $266.5B | $332.1B | $387.3B | $352.5B | $337.9B | |
| Levered Free Cash Flow | $68.4B | $54.4B | $78.3B | $29.9B | $47.4B | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $118.7B | $128.5B | $204.9B | $231B | $210B | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.6B | $6.9B | $4.7B | $5.7B | $5.3B | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $68.4B | $54.4B | $78.3B | $29.9B | $47.4B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$22.1B | -$4.7B | -$18.8B | -$18.5B | -$20.6B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $3.9B | -$3.6B | -$6.9B | -$239.1M | $209.4M | |
| Beginning Cash (CF) | $206.6B | $293.7B | $325.9B | $349B | $312.9B | |
| Foreign Exchange Rate Adjustment | $9.7B | -$7.7B | $8.9B | -$7.6B | -$2B | |
| Additions / Reductions | $50.2B | $46.1B | $52.6B | $11.2B | $27B | |
| Ending Cash (CF) | $266.5B | $332.1B | $387.3B | $352.5B | $337.9B | |
| Levered Free Cash Flow | $68.4B | $54.4B | $78.3B | $29.9B | $47.4B | |
Get BCS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BCS
Sector
P/E ratio
8.95x
12.02x
PEG ratio
--
0.36x
P/B ratio
0.50x
1.05x
Price / LTM sales
1.51x
2.55x
Growth Metrics
BCS
Sector
Revenue growth
7.51%
6.08%
Earnings growth
32.48%
6.45%
Revenue (5-year growth)
2.3%
5.85%
Earnings forecast
$0.40
$0.56
Profitability
BCS
Sector
Profitability FY 2024
--
$179.9M
Return on invested capital
2.69%
5.27%
Return on assets
0.34%
0.98%
Return on equity
7.35%
9.43%
Earnings Date
Last Earnings Date
Oct
24
Next Earnings Date
Feb
13
Estimated Next Earnings Date
Jan
23
Balance Sheet
BCS
Sector
Total cash
$287.8B
$617M
Short term investments
--
$408.4M
Total assets
$1.9T
$4.5B
Long term debt
$134.8B
$270.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
